News

CSCI's Teichmann Lab and GSK announce new partnership to advance our understanding of the role of cells and tissues in disease, paving the way for new medical breakthroughs

13 January 2026

The collaboration, announced last month, will use state-of-the-art genomics approaches in combination with machine learning methods to advance our scientific understanding of cells and tissues in health and disease. GSK is investing nearly £10 million in this ground-breaking alliance that brings together the expertise of...

CSCI celebrates fourth annual Christmas Market at JCBC!

8 December 2025

On Friday 5 December, CSCI celebrated our fourth annual Christmas Market at the Jeffrey Cheah Biomedical Centre . Partnering with our neighbours at Cancer Research UK Cambridge Institute , Cambridge Biomedical Campus , The Milner Therapeutics Institute , and Cambridge Institute of Therapeutic Immunology & Infectious...

CSCI’s Professor Sarah Teichmann elected to the US National Academy of Medicine

21 October 2025

Professor Sarah Teichmann (Chair in Stem Cell Medicine, Cambridge Stem Cell Institute, Department of Medicine, University of Cambridge) has been elected to the prestigious National Academy of Medicine in the USA. She was announced as one of 90 new regular members and 10 new international members during the annual meeting...

Bertie Göttgens joins Stem Cell Reports as a new Editorial Board member

3 October 2025

Stem Cell Reports , the official journal of the International Society for Stem Cell Research, has just welcomed Cambridge Stem Cell Institute Director Bertie Göttgens as one of 13 new distinguished researchers to the Editorial Board. The new appointments are designed to broaden representation across the international...

New research uncovers link between telomere shortening and age-related blood mutations driving leukaemia

29 August 2025

A groundbreaking study led by Professor George Vassiliou at the Cambridge Stem Cell Institute and University of Cambridge has revealed that age-related telomere shortening plays a key role in the development of clonal haematopoiesis (CH) and blood cancers driven by mutations in RNA splicing genes. The findings, published...

Watch our new Institute video now! A Place of Possibility

15 July 2025

We are very excited to launch our new institute video, A Place of Possibility / Cambridge Stem Cell Institute, showcasing some of the people that form our research community. Watch this three-minute video to hear from our students, postdocs, facilities team, admin team, and Director as they demonstrate how the...

Photo collage of retreat presentation, registration team, and pub quiz hosts

Celebrating Institute research and accomplishments at the 2025 Retreat & Symposium

1 July 2025

Last Thursday and Friday, the Institute held the CSCI Annual Retreat & Symposium on 26 and 27 June in Cambridge. This annual event brings together CSCI researchers, Affiliate Group Leaders, and our Stem Cells Interdisciplinary Research Centre members for a day and a half of talks, posters, Institute updates, and...

Image of someone receiving a shot in their arm; image of Professor Walid Khaled

Professor Walid Khaled awarded ERC Advanced Grant for breast cancer research

18 June 2025

Yesterday the European Research Council (ERC) announced the winners of its latest Advanced Grant competition. CSCI’s Professor Walid Khaled was selected as one of 281 leading researchers across Europe to receive some of the 721 million euros in funding to pursue his breast cancer research. The ERC fund will provide €2.5...

Matt Zilbauer at the launch of the event

Professor Zilbauer opens new Cambridge centre, aiming to transform physical and mental health of children with inflammatory bowel diseases

11 June 2025

This past weekend, Professor Matthias Zilbauer of CSCI launched the new Cambridge Centre for Children’s Gut Health, welcoming over 100 children living with inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Zilbauer, Professor of Paediatric Gastroenterology at the University of Cambridge and...

CSCI & Department of Haematology scientists develop new treatment with potential to tackle common form of childhood cancer

20 May 2025

Research out this week finds that a combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the most common cancer in childhood and one that can be particularly difficult to treat in older patients. In recent years, new treatments have...